Literature DB >> 20431937

Time trends in pharyngeal cancer incidence in Norway 1981-2005: a subsite analysis based on a reabstraction and recoding of registered cases.

Jon Mork1, Bjørn Møller, Tove Dahl, Freddie Bray.   

Abstract

OBJECTIVE: Incidence rates of oropharyngeal squamous cell carcinoma (SCC) have been reported to be increasing in several countries in recent decades, contrasting with trends of SCCs diagnosed in neighboring anatomical sites. We investigated whether changes in classification systems and/or coding/registration practices might explain the trends in Norway, focusing on changes in oropharyngeal cancer.
METHODS: Trends in cancers of the oropharynx, base of tongue, nasopharynx, hypopharynx were graphically presented for the period 1981-2005, before and after recoding. Age-period-cohort and future prediction models were fitted to oropharyngeal SCC incidence.
RESULTS: A total of 85 (3.7%) of the 2315 pharyngeal cancers required recoding. Rates of oropharyngeal cancer in Norway were consistently two to three times higher in men, with rapid increases in both men (5% per annum) and women (4.2% per annum). Assuming generational effects, male cohorts born 1915-1950 were at increasingly higher risk of the disease. The number of oropharyngeal cancer cases is expected to double in Norway by 2020.
CONCLUSIONS: The trends were not considered materially biased by potential artefacts. The increasingly higher proportion of oropharyngeal SCC cancers is more likely explained by other factors, including an increasing high-risk HPV prevalence among recent cohorts. These results will likely have consequences on treatment and health care provision in the near future.

Entities:  

Mesh:

Year:  2010        PMID: 20431937     DOI: 10.1007/s10552-010-9567-9

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  19 in total

Review 1.  Epidemiology and clinical aspects of HPV in head and neck cancers.

Authors:  Anil K Chaturvedi
Journal:  Head Neck Pathol       Date:  2012-07-03

Review 2.  Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma.

Authors:  Maura L Gillison; Anil K Chaturvedi; William F Anderson; Carole Fakhry
Journal:  J Clin Oncol       Date:  2015-09-08       Impact factor: 44.544

3.  Human papillomavirus in oropharyngeal squamous cell carcinoma in South-Eastern Norway: prevalence, genotype, and survival.

Authors:  Guro Haugen Fossum; Agnes Kathrine Lie; Peter Jebsen; Lars Erik Sandlie; Jon Mork
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-09-20       Impact factor: 2.503

4.  Pre-diagnostic dynamic HPV16 IgG seropositivity and risk of oropharyngeal cancer.

Authors:  Karen S Anderson; Garrick Wallstrom; Hilde Langseth; Marshall Posner; Julia N Cheng; Rizwan Alam; Diego Chowell; Ingegerd E Furre; Jon Mork
Journal:  Oral Oncol       Date:  2017-09-01       Impact factor: 5.337

5.  Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer.

Authors:  Aimée R Kreimer; Mattias Johansson; Elizabeth L Yanik; Hormuzd A Katki; David P Check; Krystle A Lang Kuhs; Martina Willhauck-Fleckenstein; Dana Holzinger; Allan Hildesheim; Ruth Pfeiffer; Craig Williams; Neal D Freedman; Wen-Yi Huang; Mark P Purdue; Angelika Michel; Michael Pawlita; Paul Brennan; Tim Waterboer
Journal:  J Natl Cancer Inst       Date:  2017-08-01       Impact factor: 13.506

6.  Incidence trends in head and neck squamous cell carcinoma in Slovenia, 1983-2009: role of human papillomavirus infection.

Authors:  Primož Strojan; Vesna Zadnik; Robert Šifrer; Boštjan Lanišnik; Vojislav Didanović; Sara Jereb; Mario Poljak; Boštjan J Kocjan; Nina Gale
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-12-27       Impact factor: 2.503

7.  [Human papillomavirus (HPV) and head and neck cancer].

Authors:  S Wagner; C Mayer; C Wittekindt; J P Klussmann
Journal:  Hautarzt       Date:  2012-01       Impact factor: 0.751

8.  Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers.

Authors:  Anil K Chaturvedi; William F Anderson; Joannie Lortet-Tieulent; Maria Paula Curado; Jacques Ferlay; Silvia Franceschi; Philip S Rosenberg; Freddie Bray; Maura L Gillison
Journal:  J Clin Oncol       Date:  2013-11-18       Impact factor: 44.544

9.  Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI.

Authors:  Aimée R Kreimer; Anil K Chaturvedi; Laia Alemany; Devasena Anantharaman; Freddie Bray; Mary Carrington; John Doorbar; Gypsyamber D'Souza; Carole Fakhry; Robert L Ferris; Maura Gillison; D Neil Hayes; Allan Hildesheim; Shao Hui Huang; Luiz P Kowalski; Krystle A Lang Kuhs; James Lewis; Douglas R Lowy; Hisham Mehanna; Andy Ness; Michael Pawlita; Maisa Pinheiro; John Schiller; Meredith S Shiels; Joseph Tota; Lisa Mirabello; Saman Warnakulasuriya; Tim Waterboer; William Westra; Stephen Chanock; Paul Brennan
Journal:  Oral Oncol       Date:  2020-06-02       Impact factor: 5.337

10.  Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer.

Authors:  Claus Wittekindt; Steffen Wagner; Christina Sabine Mayer; Jens Peter Klussmann
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.